This coverage policy addresses stem cell therapy for orthopaedic applications in particular mesenchymal stem cells mscs.
Mesenchymal stem cell therapy applications.
Adult mesenchymal stem cells are being used by researchers in the fields of regenerative medicine and tissue engineering to artificially reconstruct human tissue which has been previously damaged.
Mscs have been proposed as a type of regenerative therapy.
Isolation characterization and potential applications of bovine mesenchymal stem cells.
Mscs are investigational products that have been studied extensively for broad clinical applications in regenerative medicine1 and for their immunomodulatory properties 2no mscs are approved by the food and drug administration fda for the treatment of covid 19.
Mesenchymal stem cells have the capacity to become any type of fully developed cell which can contribute to replacing muscle tissues or internal organs.
Bovine mesenchymal stem cells have been isolated from the uterus umbilical cord bone marrow adipose tissue placenta and fetal fluids.
Mesenchymal stem cell therapy is considered investigational for all orthopedic applications including use in repair or regeneration of musculoskeletal tissue.
Much of the current interest in therapeutic application of mscs to various disease settings can be linked to their immunosuppressive and anti inflammatory properties.
Among all kinds of stem cells mesenchymal stem cells mscs have been shown to be an interesting therapeutic option due to their immunomodulatory properties and their potential for in vitro differentiation into insulin secreting cells.
Allograft bone products containing viable stem cells including but not limited to demineralized bone matrix with stem cells are considered investigational for all orthopedic applications.
Allograft bone products containing viable stem cells including but not limited to demineralized bone matrix with stem cells are considered experimental.
Mesenchymal stem stromal cells are one of the most commonly studied stem cell populations and the most commonly used cell based therapy for neurodegenerative cardiovascular and other diseases in clinical trials because of their regenerative effects.
There are insufficient data to assess use of mscs for the treatment of covid 19.
To help discover the therapeutic uses of these stem cells they are grown in laboratories or by using medication to stimulate new cell growth within.
Mesenchymal stem stromal cells mscs are multipotent cells with the ability to differentiate into several cell types thus serving as a cell reservoir for regenerative medicine.
Regenerative therapy is considered an emerging field of medicine focusing on repair replacement or regeneration of cells and tissues.